Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

C.A. Lasagna-Reeves, D.L. Castillo-Carranza, U. Sengupta, M.J. Guerrero-Munoz, T. Kiritoshi, V. Neugebauer, G.R. Jackson, R. Kayed

Research output: Contribution to journalArticlepeer-review

360 Citations (Scopus)


Intracerebral injection of brain extracts containing amyloid or tau aggregates in transgenic animals can induce cerebral amyloidosis and tau pathology. We extracted pure populations of tau oligomers directly from the cerebral cortex of Alzheimer disease (AD) brain. These oligomers are potent inhibitors of long term potentiation (LTP) in hippocampal brain slices and disrupt memory in wild type mice. We observed for the first time that these authentic brain-derived tau oligomers propagate abnormal tau conformation of endogenous murine tau after prolonged incubation. The conformation and hydrophobicity of tau oligomers play a critical role in the initiation and spread of tau pathology in the naïve host in a manner reminiscent of sporadic AD.

Original languageEnglish
Article number700
Pages (from-to)700
JournalScientific Reports
Publication statusPublished - 2012
Externally publishedYes

Bibliographical note

Funding Information:
We thank Dr. Bridget Hawkins for useful suggestions. We are grateful to Shashirekha Krishnamurthy and Malika Farhed for excellent technical assistance, as well as to Drs. Adriana Paulucci, Mathieu Bakhoum, and Yogesh Wairkar for their help with microscopy and image analysis. This work was supported by: The Cullen Family Trust for Health Care, the Alzheimer’s Drug Discovery Foundation (ADDF), the Michael J. Fox Foundation, and the Mitchell Center for Neurodegenerative Diseases.

Copyright 2012 Elsevier B.V., All rights reserved.

All Science Journal Classification (ASJC) codes

  • General


Dive into the research topics of 'Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau'. Together they form a unique fingerprint.

Cite this